Effect of Flexible Sigmoidoscopy Screening on Colorectal Cancer Incidence and Mortality: A Randomized Clinical Trial
Open accessThe DOI matches its Crossref record; 27 of the 27 references it cites were found in a registry or an index.
Abstract
IMPORTANCE: Colorectal cancer is a major health burden. Screening is recommended in many countries. OBJECTIVE: To estimate the effectiveness of flexible sigmoidoscopy screening on colorectal cancer incidence and mortality in a population-based trial. DESIGN, SETTING, AND PARTICIPANTS: Randomized clinical trial of 100,210 individuals aged 50 to 64 years, identified from the population of Oslo city and Telemark County, Norway. Screening was performed in 1999-2000 (55-64-year age group) and in 2001 (50-54-year age group), with follow-up ending December 31, 2011. Of those selected, 1415 were excluded due to prior colorectal cancer, emigration, or death, and 3 could not be traced in the population registry. INTERVENTIONS: Participants randomized to the screening group were invited to undergo screening. Within the screening group, participants were randomized 1:1 to receive once-only flexible sigmoidoscopy or combination of once-only flexible sigmoidoscopy and fecal occult blood testing (FOBT). Participants with positive screening test results (cancer, adenoma, polyp ≥10 mm, or positive FOBT) were offered colonoscopy. The control group received no intervention. MAIN OUTCOMES AND MEASURES: Colorectal cancer incidence and mortality. RESULTS: A total of 98,792 participants were included in the intention-to-screen analyses, of whom 78,220 comprised the control group and 20,572 comprised the screening group (10,283 randomized to receive a flexible sigmoidoscopy and 10,289 to receive flexible sigmoidoscopy and FOBT). Adherence with screening was 63%. After a median of 10.9 years, 71 participants died of colorectal cancer in the screening group vs 330 in the control group (31.4 vs 43.1 deaths per 100,000 person-years; absolute rate difference, 11.7 [95% CI, 3.0-20.4]; hazard ratio [HR], 0.73 [95% CI, 0.56-0.94]). Colorectal cancer was diagnosed in 253 participants in the screening group vs 1086 in the control group (112.6 vs 141.0 cases per 100,000 person-years; absolute rate difference, 28.4 [95% CI, 12.1-44.7]; HR, 0.80 [95% CI, 0.70-0.92]). Colorectal cancer incidence was reduced in both the 50- to 54-year age group (HR, 0.68; 95% CI, 0.49-0.94) and the 55- to 64-year age group (HR, 0.83; 95% CI, 0.71-0.96). There was no difference between the flexible sigmoidoscopy only vs the flexible sigmoidoscopy and FOBT screening groups. CONCLUSIONS AND RELEVANCE: In Norway, once-only flexible sigmoidoscopy screening or flexible sigmoidoscopy and FOBT reduced colorectal cancer incidence and mortality on a population level compared with no screening. Screening was effective both in the 50- to 54-year and the 55- to 64-year age groups. TRIAL REGISTRATION: clinicaltrials.gov Identifier: NCT00119912.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008
Ferlay, J., Shin, H., Bray, F., Forman, D., Mathers, C., & Parkin, D. M. (2010) · International Journal of Cancer · doi:10.1002/ijc.25516 · Cited by 21,293
Reducing Mortality from Colorectal Cancer by Screening for Fecal Occult Blood
Mandel, J. S., Bond, J. H., Church, T. R., Snover, D. C., Bradley, G. M., Schuman, L. M., & Ederer, F. (1993) · New England Journal of Medicine · doi:10.1056/nejm199305133281901 · Cited by 3,229
Levin, B., Lieberman, D. A., McFarland, B., Andrews, K. S., Brooks, D., Bond, J., Dash, C., Giardiello, F. M., Glick, S., Johnson, D., et al. (2008) · Gastroenterology · doi:10.1053/j.gastro.2008.02.002 · Cited by 2,990
Randomised controlled trial of faecal-occult-blood screening for colorectal cancer
Hardcastle, J. D., Chamberlain, J. O., Robinson, M. H., Moss, S. M., Amar, S. S., Balfour, T. W., James, P. D., & Mangham, C. M. (1996) · The Lancet · doi:10.1016/s0140-6736(96)03386-7 · Cited by 2,793
Randomised study of screening for colorectal cancer with faecal-occult-blood test
Kronborg, O., Fenger, C., Olsen, J., Jørgensen, O. D., & Søndergaard, O. (1996) · The Lancet · doi:10.1016/s0140-6736(96)03430-7 · Cited by 2,501
The evolution of cancer of the colon and rectum
Muto, T., Bussey, H. J. R., & Morson, B. C. (1975) · Cancer · doi:10.1002/cncr.2820360944 · Cited by 2,118
Use of Colonoscopy to Screen Asymptomatic Adults for Colorectal Cancer
Lieberman, D. A., Weiss, D. G., Bond, J. H., Ahnen, D. J., Garewal, H., Harford, W. V., Provenzale, D., Sontag, S., Schnell, T., Durbin, T. E., et al. (2000) · New England Journal of Medicine · doi:10.1056/nejm200007203430301 · Cited by 1,815
Atkin, W. S., Edwards, R., Kralj-Hans, I., Wooldrage, K., Hart, A. R., Northover, J. M., Parkin, D. M., Wardle, J., Duffy, S. W., & Cuzick, J. (2010) · The Lancet · doi:10.1016/s0140-6736(10)60551-x · Cited by 1,623
Imperiale, T. F., Wagner, D. R., Lin, C. Y., Larkin, G. N., Rogge, J. D., & Ransohoff, D. F. (2000) · New England Journal of Medicine · doi:10.1056/nejm200007203430302 · Cited by 1,060
Colorectal-Cancer Incidence and Mortality with Screening Flexible Sigmoidoscopy
Schoen, R. E., Pinsky, P. F., Weissfeld, J. L., Yokochi, L. A., Church, T., Laiyemo, A. O., Bresalier, R., Andriole, G. L., Buys, S. S., Crawford, E. D., et al. (2012) · New England Journal of Medicine · doi:10.1056/nejmoa1114635 · Cited by 1,021
Cited by
Dekker, E., Tanis, P. J., Vleugels, J. L. A., Kasi, P. M., & Wallace, M. B. (2019) · The Lancet · doi:10.1016/s0140-6736(19)32319-0 · Cited by 4,974
Screening for Colorectal Cancer: US Preventive Services Task Force Recommendation Statement
US Preventive Services Task Force, Bibbins-Domingo, K., Grossman, D. C., Curry, S. J., Davidson, K. W., Epling, J. W., García, F. A. R., Gillman, M. W., Harper, D. M., Kemper, A. R., et al. (2016) · JAMA · doi:10.1001/jama.2016.5989 · Cited by 2,509
Wolf, A. M. D., Fontham, E. T. H., Church, T. R., Flowers, C. R., Guerra, C. E., LaMonte, S. J., Etzioni, R., McKenna, M. T., Oeffinger, K. C., Shih, Y. T., et al. (2018) · CA: A Cancer Journal for Clinicians · doi:10.3322/caac.21457 · Cited by 1,944
Colorectal cancer screening: a global overview of existing programmes
Schreuders, E. H., Ruco, A., Rabeneck, L., Schoen, R. E., Sung, J. J. Y., Young, G. P., & Kuipers, E. J. (2015) · Gut · doi:10.1136/gutjnl-2014-309086 · Cited by 1,328
Lin, J. S., Bowles, E. J. A., Williams, S. B., & Morrison, C. C. (2017) · JAMA · doi:10.1001/jama.2017.0562 · Cited by 1,082
Jacobs, I. J., Menon, U., Ryan, A., Gentry-Maharaj, A., Burnell, M., Kalsi, J. K., Amso, N. N., Apostolidou, S., Benjamin, E., Cruickshank, D., et al. (2016) · The Lancet · doi:10.1016/s0140-6736(15)01224-6 · Cited by 1,048
ACG Clinical Guidelines: Colorectal Cancer Screening 2021
Shaukat, A., Kahi, C. J., Burke, C. A., Rabeneck, L., Sauer, B. G., & Rex, D. K. (2021) · American Journal of Gastroenterology · doi:10.14309/ajg.0000000000001122 · Cited by 853
Effect of Colonoscopy Screening on Risks of Colorectal Cancer and Related Death
Bretthauer, M., Løberg, M., Wieszczy, P., Kalager, M., Emilsson, L., Garborg, K., Rupinski, M., Dekker, E., Spaander, M., Bugajski, M., et al. (2022) · New England Journal of Medicine · doi:10.1056/nejmoa2208375 · Cited by 817
Self-citationNutrients, foods, and colorectal cancer prevention
Song, M., Garrett, W. S., & Chan, A. T. (2015) · Gastroenterology · doi:10.1053/j.gastro.2014.12.035 · Cited by 700
Per-Protocol Analyses of Pragmatic Trials
Hernán, M. A., & Robins, J. M. (2017) · New England Journal of Medicine · doi:10.1056/nejmsm1605385 · Cited by 660
Self-citationLin, J. S., Perdue, L. A., Henrikson, N. B., Bean, S. I., & Blasi, P. R. (2021) · JAMA · doi:10.1001/jama.2021.4417 · Cited by 650
Colorectal cancer screening: An updated review of the available options
Issa, I. A., & Noureddine, M. (2017) · World Journal of Gastroenterology · doi:10.3748/wjg.v23.i28.5086 · Cited by 572
Levin, T. R., Corley, D. A., Jensen, C. D., Schottinger, J. E., Quinn, V. P., Zauber, A. G., Lee, J. K., Zhao, W. K., Udaltsova, N., Ghai, N. R., et al. (2018) · Gastroenterology · doi:10.1053/j.gastro.2018.07.017 · Cited by 554
Why Test for Proportional Hazards?
Stensrud, M. J., & Hernán, M. A. (2020) · JAMA · doi:10.1001/jama.2020.1267 · Cited by 532
Self-citationCurrent and future colorectal cancer screening strategies
Shaukat, A., & Levin, T. R. (2022) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/s41575-022-00612-y · Cited by 516
Knudsen, A. B., Zauber, A. G., Rutter, C. M., Naber, S. K., Doria-Rose, V. P., Pabiniak, C., Johanson, C., Fischer, S. E., Lansdorp-Vogelaar, I., & Kuntz, K. M. (2016) · JAMA · doi:10.1001/jama.2016.6828 · Cited by 474
Doubeni, C. A., Corley, D. A., Quinn, V. P., Jensen, C. D., Zauber, A. G., Goodman, M., Johnson, J. R., Mehta, S. J., Becerra, T. A., Zhao, W. K., et al. (2018) · Gut · doi:10.1136/gutjnl-2016-312712 · Cited by 409
Testa, U., Pelosi, E., & Castelli, G. (2018) · Medical Sciences · doi:10.3390/medsci6020031 · Cited by 374
Atkin, W., Wooldrage, K., Parkin, D. M., Kralj-Hans, I., MacRae, E., Shah, U., Duffy, S., & Cross, A. J. (2017) · The Lancet · doi:10.1016/s0140-6736(17)30396-3 · Cited by 358
The IARC Perspective on Colorectal Cancer Screening
Lauby-Secretan, B., Vilahur, N., Bianchini, F., Guha, N., & Straif, K. (2018) · New England Journal of Medicine · doi:10.1056/nejmsr1714643 · Cited by 352
Population-Based Colonoscopy Screening for Colorectal Cancer: A Randomized Clinical Trial
Bretthauer, M., Kaminski, M. F., Løberg, M., Zauber, A. G., Regula, J., Kuipers, E. J., Hernán, M. A., McFadden, E., Sunde, A., Kalager, M., et al. (2016) · JAMA Internal Medicine · doi:10.1001/jamainternmed.2016.0960 · Cited by 323
Self-citationAssociation of Colonoscopy Adenoma Findings With Long-term Colorectal Cancer Incidence
Click, B., Pinsky, P. F., Hickey, T., Doroudi, M., & Schoen, R. E. (2018) · JAMA · doi:10.1001/jama.2018.5809 · Cited by 311
Brenner, H., & Chen, C. (2018) · British Journal of Cancer · doi:10.1038/s41416-018-0264-x · Cited by 295
Zauber, A. G. (2015) · Digestive Diseases and Sciences · doi:10.1007/s10620-015-3600-5 · Cited by 289
Long-term Risk of Colorectal Cancer After Removal of Conventional Adenomas and Serrated Polyps
He, X., Hang, D., Wu, K., Nayor, J., Drew, D. A., Giovannucci, E. L., Ogino, S., Chan, A. T., & Song, M. (2020) · Gastroenterology · doi:10.1053/j.gastro.2019.06.039 · Cited by 288
Diagnostics and Epidemiology of Colorectal Cancer
Kolligs, F. T. (2016) · Visceral Medicine · doi:10.1159/000446488 · Cited by 223
Screening for Colorectal Cancer
Gupta, S. (2022) · Hematology/Oncology Clinics of North America · doi:10.1016/j.hoc.2022.02.001 · Cited by 212
Long-term risk of colorectal cancer in individuals with serrated polyps
Holme, Ø., Bretthauer, M., Eide, T. J., Løberg, E. M., Grzyb, K., Løberg, M., Kalager, M., Adami, H.-O., Kjellevold, Ø., & Hoff, G. (2015) · Gut · doi:10.1136/gutjnl-2014-307793 · Cited by 188
Self-citationAn introduction to instrumental variable assumptions, validation and estimation
Lousdal, M. L. (2018) · Emerging Themes in Epidemiology · doi:10.1186/s12982-018-0069-7 · Cited by 173
Colonoscopy screening and surveillance guidelines
Saito, Y., Oka, S., Kawamura, T., Shimoda, R., Sekiguchi, M., Tamai, N., Hotta, K., Matsuda, T., Misawa, M., Tanaka, S., et al. (2021) · Digestive Endoscopy · doi:10.1111/den.13972 · Cited by 170
Pan, J., Xin, L., Ma, Y.-F., Hu, L.-H., & Li, Z.-S. (2016) · American Journal of Gastroenterology · doi:10.1038/ajg.2015.418 · Cited by 158
Atkin, W., Cross, A. J., Kralj-Hans, I., MacRae, E., Piggott, C., Pearson, S., Wooldrage, K., Brown, J., Lucas, F., Prendergast, A., et al. (2019) · Health Technology Assessment · doi:10.3310/hta23010 · Cited by 129
Optimising colorectal cancer screening acceptance: a review
Senore, C., Inadomi, J., Segnan, N., Bellisario, C., & Hassan, C. (2015) · Gut · doi:10.1136/gutjnl-2014-308081 · Cited by 121
Murray, E. J., & Hernán, M. A. (2016) · Clinical Trials · doi:10.1177/1740774516634335 · Cited by 57
“For example, Holme et al.15 demonstrated that the mortality rate was greater in participants who refused to undergo a sigmoidoscopy compared with those who did undergo sigmoidoscopy, even after adjustment for multiple factors.”
BackgroundMethodSelf-citationScreening and Surveillance of Colorectal Cancer: A Review of the Literature
Maida, M., Dahiya, D. S., Shah, Y. R., Tiwari, A., Gopakumar, H., Vohra, I., Khan, A., Jaber, F., Ramai, D., & Facciorusso, A. (2024) · Cancers · doi:10.3390/cancers16152746 · Cited by 43
Metadata
- Authors
- Holme, Ø., Løberg, M., Kalager, M., Bretthauer, M., Hernán, M. A., Aas, E., Eide, T. J., Skovlund, E., Schneede, J., Tveit, K. M., & Hoff, G.
- Venue
- JAMA
- Publisher
- American Medical Association (AMA)
- Published
- 2014-08-13
- Volume
- 312
- Issue
- 6
- Pages
- 606
- ISSN
- 0002-9955 (ISSN-L)
- 0098-7484
- OpenAlex
- W2087147904
- Cited by
- 425
- References
- 27
- FWCI
- 21.69
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.